Allspring Global Investments’s Caribou Biosciences CRBU Stock Holding History

Allspring Global Investments’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-42,653	Closed	-$219K	–	2409
2024 Q1	$219K	Buy	42,653 +3,594	+9%	+$22.2K	﹤0.01%	1687
2023 Q4	$224K	Buy	+39,059	New	+$193K	﹤0.01%	1667
2023 Q1	–	Sell	-661	Closed	-$4.15K	–	2800
2022 Q4	$4.15K	Sell	661 -15	-2%	-$133	﹤0.01%	2795
2022 Q3	$7K	Buy	+676	New	+$6.3K	﹤0.01%	2760
2022 Q2	–	Sell	-8,043	Closed	-$73K	–	2737
2022 Q1	$73K	Sell	8,043 -14,120	-64%	-$149K	﹤0.01%	2798
2021 Q4	$334K	Buy	+22,163	New	+$431K	﹤0.01%	2458

Other funds holding CRBU

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

EWM

Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allspring Global Investments's CRBU Position: Q2 2024 in Review

Allspring Global Investments sold out of Caribou Biosciences (CRBU) in Q2 2024, closing a stake of 42,653 shares — an estimated $219K sold.

Allspring Global Investments first reported a position in CRBU in Q4 2021 and held it in 6 quarters. The position peaked at $334K in Q4 2021. 140 funds tracked by Wall St. Rank hold CRBU as of Q2 2024.

Allspring Global Investments reported no remaining Caribou Biosciences position as of Q2 2024 after selling out during the quarter.
Allspring Global Investments sold 42,653 Caribou Biosciences shares in Q2 2024, an estimated $219K.
Allspring Global Investments first reported a position in Caribou Biosciences in Q4 2021 and held it in 6 quarters.
Allspring Global Investments's Caribou Biosciences position peaked at $334K in Q4 2021.
140 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2024.

Based on Allspring Global Investments's 13F filing for Q2 2024, filed 26 Jul 2024.